PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Similar documents
Package leaflet: Information for the user. Tobramycin 40 mg/ml Solution for Injection tobramycin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Calcium Folinate 10 mg/ml Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml Solution for Injection/Infusion Cisatracurium 5 mg/ml Solution for Injection/Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Atracurium Besilate 10 mg/ml Solution for Injection The active substance is atracurium besilate

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 100 mg/ml Injection

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Aciclovir 25 mg/ml Concentrate for Solution for Infusion (Sterile Concentrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cytarabine 100 mg/ml Injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vincristine Sulphate 1 mg/ml Injection (1 mg/1 ml and 2 mg/2 ml vials)

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

Package leaflet: Information for the user

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

What is in this leaflet:

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Package leaflet Information for the user. Cytarabine 100 mg/ml Injection cytarabine

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Package leaflet: Information for the patient. Chlorphenamine 10 mg/ml Solution for Injection (Chlorphenamine Maleate)

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Dobutamine 12.5mg/ml Concentrate for Solution for Infusion Dobutamine Hydrochloride

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

1. What Xylocaine with adrenaline is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Package leaflet: Information for the user. Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion topotecan

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

Package leaflet: Information for the patient. Gemcitabine 10 mg/ml, solution for infusion. gemcitabine

Package leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

Package leaflet: Information for the user. Midazolam 2 mg/ml Solution for Injection or Infusion Midazolam 5 mg/ml Solution for Injection or Infusion

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fluorouracil 50 mg/ml Injection

2. What you need to know before Marcain Polyamp Steripack is given to you

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package leaflet: Information for the user. ReoPro 2 mg/ml solution for injection or infusion. abciximab

1. What Naropin is and what it is used for

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

PACKAGE LEAFLET. Package leaflet: Information for the user. Vancomycin Hospira 1000 mg Powder for concentrate for solution for infusion.

Package leaflet: Information for the user. Pharmalgen Bee Venom Pharmalgen Wasp Venom. 100μg/ml. powder and solvent for solution for injection

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Meptid 100 mg/ml Solution for Injection. Meptazinol

PACKAGE LEAFLET: INFORMATION FOR THE USER Etoposide Accord 20 mg/ml Concentrate for Solution for Infusion Etoposide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Gemzar 200 mg powder for solution for infusion Gemzar 1000 mg powder for solution for infusion Gemcitabine

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

Package leaflet: Information for the patient. xylometazoline hydrochloride

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

1. What Miacalcic is and what it is used for

PATIENT INFORMATION LEAFLET. MIDORYX (MIDAZOLAM INJECTION 5mg, 10mg BP)

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PRIMAXIN Imipenem/Cilastatin sodium

Package leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection

Imodium 1 mg/5 ml oral solution

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the user. Zoledronic Acid Accord 4 mg/5 ml concentrate for solution for infusion Zoledronic acid

Oxytocin APOTEX Solution for Injection Contains the active ingredient synthetic oxytocin

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration

Package Leaflet: Information for the User

Package leaflet: Information for the user. TRISENOX 1 mg/ml concentrate for solution for infusion arsenic trioxide

Package leaflet: Information for the patient. Lacosamide G.L. 10 mg/ml solution for infusion lacosamide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 10 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dacepton 10 mg/ml solution for injection/infusion Apomorphine hydrochloride hemihydrate

Package leaflet: Information for the user. Lidocaine Hydrochloride Anhydrous 2% w/v Adrenaline (epinephrine) 1:80,000

IMIPENEM+CILASTATIN RBX

PACKAGE LEAFLET: INFORMATION FOR THE USER. Variquel 1 mg powder and solvent for solution for injection Terlipressin acetate

PATIENT INFORMATION LEAFLET. DOTAREM mg/ml, solution for injection (Gadoteric acid)

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

Package leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine

Package leaflet: Information for the user Efedrin Stragen 3mg/ml, solution for injection Ephedrine hydrochloride

Motens 2 mg and 4 mg Tablets lacidipine

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

Package Leaflet: Information for the user. MAGNEVIST 2 mmol/l solution for injection dimeglumine gadopentetate

Package leaflet: Information for the user. DaunoXome Injection 2mg/ml Concentrate for Solution for Infusion Daunorubicin

Package leaflet: Information for the user. Chirocaine 2.5 mg/ml and 5.0 mg/ml solution for injection/concentrate for solution for infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate

Package leaflet: Information for the user. Carmellose sodium

Ventolin Accuhaler 200 micrograms salbutamol sulfate

TYPHIM Vi, Solution for injection

PACKAGE LEAFLET: INFORMATION FOR THE USER. Adrenaline

Package leaflet: Information for the user

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Dopamine 40 mg/ml Sterile Concentrate Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. In this leaflet: 1. What Dopamine Sterile Concentrate is and what it is used for 2. Before Dopamine Sterile Concentrate is used 3. How Dopamine Sterile Concentrate is used 4. Possible side effects 5. How Dopamine Sterile Concentrate is stored 6. Further information 1. WHAT DOPAMINE STERILE CONCENTRATE IS AND WHAT IT IS USED FOR Dopamine is a medicine that stimulates the heart and has effects on the blood vessels. Dopamine Sterile Concentrate can be used: to treat low blood pressure or shock (reduction of blood flow through the body tissues) after a heart attack, blood poisoning, trauma (injury) or kidney failure in combination with other treatments where low blood pressure occurs after open heart surgery in congestive heart failure (heart failure due to a build up of fluid/blood) 2. BEFORE DOPAMINE STERILE CONCENTRATE IS USED Dopamine Sterile Concentrate should not be used if you have a tumour that causes an increase in blood pressure if you have an overactive thyroid gland if you have irregular or rapid heartbeats if you have shown signs of hypersensitivity (severe allergy) to dopamine or sodium metabisulphite in the past If possible, tell your doctor if any of the above applies to you before this medicine is used. Special care needs to be taken with Dopamine Sterile Concentrate if you have diabetes if you have kidney or liver problems

if you have a history of blood circulation problems (you will be monitored for any changes in colour or temperature of your fingers or toes) If possible, tell your doctor if any of the above applies to you before this medicine is used. Taking/using other medicines Special care is needed if you are taking/using other medicines as some could interact with dopamine, for example: anaesthetics (dopamine should not be used with cyclopropane and halogenated hydrocarbon anaesthetics) alpha- and beta-blockers, e.g. propranolol (medicines which are often used for treating blood pressure and heart disorders) monoamine oxidase inhibitors (anti-depressant medicines) phenytoin (a medicine used to treat epilepsy) If possible, please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy and breast-feeding Tell your doctor if you are pregnant, trying to become pregnant or breast-feeding. Your doctor will only use this medicine if the expected benefits outweigh any potential risk to your baby. Ask your doctor or pharmacist for advice before taking any medicine. Driving and using machines Do not drive or use machines if you experience any side effect (e.g. dizziness or difficulty seeing in bright light) which may lessen your ability to do so. Important information about some of the ingredients of Dopamine Sterile Concentrate This medicinal product contains sodium metabisulphite which, rarely, may cause severe hypersensitivity (severe allergy) reactions and bronchospasm (breathing difficulties). This medicinal product contains less than 1 mmol (23 mg) sodium per ampoule, i.e. essentially sodium free. 3. HOW DOPAMINE STERILE CONCENTRATE IS USED This medicine will be diluted before it is given to you. It will be given as an infusion (drip) into a vein. Dose If your blood volume is low, you may be given a transfusion of blood or a plasma expander before dopamine is given. Your doctor will work out the correct dose of dopamine for you and how often it must be given. The dose will depend upon your medical condition and your size.

The rate of administration will be carefully controlled and adjusted according to your response. During treatment your heart rate, blood pressure and urine output will be measured to check how you are responding. If you are given too much or too little Dopamine Sterile Concentrate This medicine will be given to you in a hospital, under the supervision of a doctor. It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns. 4. POSSIBLE SIDE EFFECTS Like all medicines, dopamine can cause side effects, although not everybody gets them. If any of the following happen, tell your doctor immediately: severe allergic reaction - you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint pain or poor circulation in your fingers or toes (you may notice a change in skin colour) pain or swelling at the injection site during or immediately after the injection severe palpitations These are serious side effects. You may need urgent medical attention. If any of the following happen, tell your doctor as soon as possible: irregular, rapid or slow heart beats chest pain shortness of breath low blood pressure (you may feel dizzy or faint, particularly when standing up or getting out of bed) feeling or being sick headache dilation of the pupil of the eye (mydriasis) which may cause difficulty seeing in bright light goose pimples Dopamine may lead to changes in your blood chemistry. Your doctor may take blood samples to monitor for these. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via United Kingdom Yellow Card Scheme Website: http://www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW DOPAMINE STERILE CONCENTRATE IS STORED Keep out of the reach and sight of children Expiry This medicine must not be used after the expiry date which is stated on the ampoule and carton after 'EXP'. Where only a month and year is stated, the expiry date refers to the last day of that month. Storage The ampoules should be kept in the outer carton, in order to protect from light, and stored at, or below, 30 C. Prepared infusions should be used immediately, however, if this is not possible they can be stored for up to 48 hours provided they have been prepared in a way to exclude microbial contamination. Visible signs of deterioration Only clear, colourless or pale yellow solutions should be used. Opaque, cloudy or discoloured solutions should be discarded. 6. FURTHER INFORMATION What Dopamine Sterile Concentrate contains The active substance is dopamine hydrochloride. Each millilitre (ml) of concentrate contains 40 milligrams (mg) of dopamine hydrochloride. The other ingredients are sodium metabisulphite and Water for Injections. section 2 for further information about sodium metabisulphite. See What Dopamine Sterile Concentrate looks like and contents of the pack Dopamine Sterile Concentrate is a clear, colourless or pale yellow concentrate for solution for infusion which comes in glass containers called ampoules. It may be supplied in packs containing: 5 x 200 mg/5 ml ampoules 50 x 200 mg/5 ml ampoules Not all packs may be marketed. Marketing authorisation holder and manufacturer Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK This leaflet was last revised in 09/2015 -------------------------------------------------------------------------------------------------------

Dopamine 40 mg/ml Sterile Concentrate The following information is intended for medical or healthcare professionals only Further to the information included in section 3, practical information on the preparation/handling of the medicinal product is provided here. Incompatibilities Dopamine Sterile Concentrate should not be added to any alkaline intravenous solutions, i.e. sodium bicarbonate. Any solution which exhibits physical or chemical incompatibility through a colour change or precipitate should not be administered. It is suggested that admixtures containing gentamicin sulphate, cephalothin sodium, cephalothin sodium neutral or oxacillin sodium should be avoided unless all other viable alternatives have been exhausted. Admixtures of ampicillin and dopamine in 5% glucose solution are alkaline and incompatible and result in decomposition of both drugs. They should not be admixed. Admixtures of dopamine, amphotericin B in 5% glucose solution are incompatible as a precipitate forms immediately on mixing. Instructions for use and handling For single use Discard any unused contents Do not use if the solution is discoloured Preparation of infusion solutions Suggested dilution Aseptically transfer Dopamine Sterile Concentrate into the IV solution as shown in the following table: Strength of Volume of IV Solution Final Concentration Concentrate concentrate Volume (ml) (ml) (microgram/ml) 200 mg/5 ml 5 500 400 200 mg/5 ml 5 250 800 200 mg/5 ml 10 250 1600 200 mg/5 ml 20 500 1600 Dopamine hydrochloride can be diluted with: Sodium chloride (0.9%) solution

Dextrose (5%), sodium chloride (0.45%) solution Sodium Lactate Intravenous Infusion, Compound (Hartmann's Solution for Injection) In use storage precautions Following dilution in the recommended diluents chemical and physical in-use stability has been demonstrated for 48 hours at a temperature not above 25 C. However, from a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8 C unless dilution has taken place in controlled and validated aseptic conditions.